COVID-19 Impact on Antidepressants Market, Global Research Reports 2020-2021

Code: QYRE-Auto-10V2889

Report

May 2020

Pages:93

QYResearch

Description

Table of Content

Tables & Figures

FEATURED COMPANIES

H.Lundbeck

Astrazeneca plc

Eli Lilly and Company

Sun Pharmaceuticals

Pfizer Inc

GlaxoSmithKline PLC

Bristol Myers Squibb Company

This report covers market size and forecasts of Antidepressants, including the following market information:

Global Antidepressants Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)

Global Antidepressants Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)

Global Antidepressants Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)

Global Antidepressants Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (K Units)

Key market players

Major competitors identified in this market include H Lundbeck, Astrazeneca, Eli Lilly and Company, Sun Pharmaceuticals, Pfizer Inc., GlaxoSmithKline, Bristol-Myers Squibb Company, Johnson & Johnson, Merck, Sanofi, etc.

Based on the Region:

Asia-Pacific (China, Japan, South Korea, India and ASEAN)

North America (US and Canada)

Europe (Germany, France, UK and Italy)

Rest of World (Latin America, Middle East & Africa)

Based on the Type:

Tricyclic Antidepressants

Selective Serotonin Reuptake Inhibitors

Selective Norepinephrine Reuptake Inhibitors

Monoamine Oxidase Inhibitors

Benzodiazepines

Antipsychotics

Novel Agents

Based on the Application:

Hospitals

Clinics

Other

FEATURED COMPANIES

H.Lundbeck

Astrazeneca plc

Eli Lilly and Company

Sun Pharmaceuticals

Pfizer Inc

GlaxoSmithKline PLC

Bristol Myers Squibb Company

1.1 Research Scope

1.2 Market Segmentation

1.3 Research Objectives

1.4 Research Methodology

1.4.1 Research Process

1.4.2 Data Triangulation

1.4.3 Research Approach

1.4.4 Base Year

1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth

1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections

1.5.2 Covid-19 Impact: Commodity Prices Indices

1.5.3 Covid-19 Impact: Global Major Government Policy

1.6 The Covid-19 Impact on Antidepressants Industry

1.7 COVID-19 Impact: Antidepressants Market Trends

2 Global Antidepressants Quarterly Market Size Analysis

2.1 Antidepressants Business Impact Assessment - COVID-19

2.1.1 Global Antidepressants Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026

2.1.2 Global Antidepressants Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026

2.2 Global Antidepressants Quarterly Market Size 2020-2021

2.3 COVID-19-Driven Market Dynamics and Factor Analysis

2.3.1 Drivers

2.3.2 Restraints

2.3.3 Opportunities

2.3.4 Challenges

3 Quarterly Competitive Assessment, 2020

3.1 Global Antidepressants Quarterly Market Size by Manufacturers, 2019 VS 2020

3.2 Global Antidepressants Factory Price by Manufacturers

3.3 Location of Key Manufacturers Antidepressants Manufacturing Factories and Area Served

3.4 Date of Key Manufacturers Enter into Antidepressants Market

3.5 Key Manufacturers Antidepressants Product Offered

3.6 Mergers & Acquisitions, Expansion Plans

4 Impact of Covid-19 on Antidepressants Segments, By Type

4.1 Introduction

1.4.1 Tricyclic Antidepressants

1.4.2 Selective Serotonin Reuptake Inhibitors

1.4.3 Selective Norepinephrine Reuptake Inhibitors

1.4.4 Monoamine Oxidase Inhibitors

1.4.5 Benzodiazepines

1.4.6 Antipsychotics

1.4.7 Novel Agents

4.2 By Type, Global Antidepressants Market Size, 2019-2021

4.2.1 By Type, Global Antidepressants Market Size by Type, 2020-2021

4.2.2 By Type, Global Antidepressants Price, 2020-2021

5 Impact of Covid-19 on Antidepressants Segments, By Application

5.1 Overview

5.5.1 Hospitals

5.5.2 Clinics

5.5.3 Other

5.2 By Application, Global Antidepressants Market Size, 2019-2021

5.2.1 By Application, Global Antidepressants Market Size by Application, 2019-2021

5.2.2 By Application, Global Antidepressants Price, 2020-2021

6 Geographic Analysis

6.1 Introduction

6.2 North America

6.2.1 Macroeconomic Indicators of US

6.2.2 US

6.2.3 Canada

6.3 Europe

6.3.1 Macroeconomic Indicators of Europe

6.3.2 Germany

6.3.3 France

6.3.4 UK

6.3.5 Italy

6.4 Asia-Pacific

6.4.1 Macroeconomic Indicators of Asia-Pacific

6.4.2 China

6.4.3 Japan

6.4.4 South Korea

6.4.5 India

6.4.6 ASEAN

6.5 Rest of World

6.5.1 Latin America

6.5.2 Middle East and Africa

7 Company Profiles

7.1 H Lundbeck

7.1.1 H Lundbeck Business Overview

7.1.2 H Lundbeck Antidepressants Quarterly Production and Revenue, 2020

7.1.3 H Lundbeck Antidepressants Product Introduction

7.1.4 H Lundbeck Response to COVID-19 and Related Developments

7.2 Astrazeneca

7.2.1 Astrazeneca Business Overview

7.2.2 Astrazeneca Antidepressants Quarterly Production and Revenue, 2020

7.2.3 Astrazeneca Antidepressants Product Introduction

7.2.4 Astrazeneca Response to COVID-19 and Related Developments

7.3 Eli Lilly and Company

7.3.1 Eli Lilly and Company Business Overview

7.3.2 Eli Lilly and Company Antidepressants Quarterly Production and Revenue, 2020

7.3.3 Eli Lilly and Company Antidepressants Product Introduction

7.3.4 Eli Lilly and Company Response to COVID-19 and Related Developments

7.4 Sun Pharmaceuticals

7.4.1 Sun Pharmaceuticals Business Overview

7.4.2 Sun Pharmaceuticals Antidepressants Quarterly Production and Revenue, 2020

7.4.3 Sun Pharmaceuticals Antidepressants Product Introduction

7.4.4 Sun Pharmaceuticals Response to COVID-19 and Related Developments

7.5 Pfizer Inc.

7.5.1 Pfizer Inc. Business Overview

7.5.2 Pfizer Inc. Antidepressants Quarterly Production and Revenue, 2020

7.5.3 Pfizer Inc. Antidepressants Product Introduction

7.5.4 Pfizer Inc. Response to COVID-19 and Related Developments

7.6 GlaxoSmithKline

7.6.1 GlaxoSmithKline Business Overview

7.6.2 GlaxoSmithKline Antidepressants Quarterly Production and Revenue, 2020

7.6.3 GlaxoSmithKline Antidepressants Product Introduction

7.6.4 GlaxoSmithKline Response to COVID-19 and Related Developments

7.7 Bristol-Myers Squibb Company

7.7.1 Bristol-Myers Squibb Company Business Overview

7.7.2 Bristol-Myers Squibb Company Antidepressants Quarterly Production and Revenue, 2020

7.7.3 Bristol-Myers Squibb Company Antidepressants Product Introduction

7.7.4 Bristol-Myers Squibb Company Response to COVID-19 and Related Developments

7.8 Johnson & Johnson

7.8.1 Johnson & Johnson Business Overview

7.8.2 Johnson & Johnson Antidepressants Quarterly Production and Revenue, 2020

7.8.3 Johnson & Johnson Antidepressants Product Introduction

7.8.4 Johnson & Johnson Response to COVID-19 and Related Developments

7.9 Merck

7.9.1 Merck Business Overview

7.9.2 Merck Antidepressants Quarterly Production and Revenue, 2020

7.9.3 Merck Antidepressants Product Introduction

7.9.4 Merck Response to COVID-19 and Related Developments

7.10 Sanofi

7.10.1 Sanofi Business Overview

7.10.2 Sanofi Antidepressants Quarterly Production and Revenue, 2020

7.10.3 Sanofi Antidepressants Product Introduction

7.10.4 Sanofi Response to COVID-19 and Related Developments

8 Supply Chain and Sales Channels Analysis

8.1 Antidepressants Supply Chain Analysis

8.1.1 Antidepressants Supply Chain Analysis

8.1.2 Covid-19 Impact on Antidepressants Supply Chain

8.2 Distribution Channels Analysis

8.2.1 Antidepressants Distribution Channels

8.2.2 Covid-19 Impact on Antidepressants Distribution Channels

8.2.3 Antidepressants Distributors

8.3 Antidepressants Customers

9 Key Findings

10 Appendix

10.1 About Us

10.2 Disclaimer

FEATURED COMPANIES

H.Lundbeck

Astrazeneca plc

Eli Lilly and Company

Sun Pharmaceuticals

Pfizer Inc

GlaxoSmithKline PLC

Bristol Myers Squibb Company

List of Tables

Table 1. Overview of the World Economic Outlook Projections

Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)

Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 7. Covid-19 Impact: Global Major Government Policy

Table 8. The Covid-19 Impact on Antidepressants Assessment

Table 9. COVID-19 Impact: Antidepressants Market Trends

Table 10. COVID-19 Impact Global Antidepressants Market Size

Table 11. Global Antidepressants Market Size Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (K Units)

Table 12. Global Antidepressants Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026, (USD/Unit)

Table 13. Global Antidepressants Quarterly Market Size, 2020 (US$ Million) & (K Units)

Table 14. Global Antidepressants Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)

Table 15. Global Antidepressants Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (K Units)

Table 16. Global Antidepressants Market Growth Drivers

Table 17. Global Antidepressants Market Restraints

Table 18. Global Antidepressants Market Opportunities

Table 19. Global Antidepressants Market Challenges

Table 20. Key Manufacturers Antidepressants Quarterly Revenue, 2019 VS 2020 (US$ Million)

Table 21. Top Manufacturers, Antidepressants Market Size, 2019 (K Units) & (US$ Million)

Table 22. Antidepressants Factory Price by Manufacturers 2020 (USD/Unit)

Table 23. Location of Key Manufacturers Antidepressants Manufacturing Plants

Table 24. Key Manufacturers Antidepressants Market Served

Table 25. Date of Key Manufacturers Enter into Antidepressants Market

Table 26. Key Manufacturers Antidepressants Product Type

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global Antidepressants Market Size by Type, 2020, (US$ Million)

Table 29. Global Antidepressants Market Size by Type, 2020 (K Units)

Table 30. Global Antidepressants Price: by Type, 2020-2021 (USD/Unit)

Table 31. Global Antidepressants Market Size by Application: 2020-2021 (US$ Million)

Table 32. Global Antidepressants Market Size by Application, 2020-2021 (K Units)

Table 33. Global Antidepressants Price: by Application, 2020-2021 (USD/Unit)

Table 34. Global Antidepressants Market Size by Region, 2019-2021 (US$ Million)

Table 35. Global Antidepressants Market Size by Region, 2019-2021 (K Units)

Table 36. By Country, North America Antidepressants Market Size, 2019-2021 (US$ Million)

Table 37. By Country, North America Antidepressants Market Size, 2019-2021 (K Units)

Table 38. US Antidepressants Market Size, 2019-2021 (US$ Million) & (K Units)

Table 39. Canada Antidepressants Market Size, 2019-2021 (US$ Million) & (K Units)

Table 40. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)

Table 41. By Country, Europe Antidepressants Market Size, 2019-2021 (US$ Million)

Table 42. By Country, Europe Antidepressants Market Size, 2019-2021 (K Units)

Table 43. Germany Antidepressants Market Size, 2019-2021 (US$ Million) & (K Units)

Table 44. France Antidepressants Market Size, 2019-2021 (US$ Million) & (K Units)

Table 45. UK Antidepressants Market Size, 2019-2021 (US$ Million) & (K Units)

Table 46. Italy Antidepressants Market Size, 2019-2021 (US$ Million) & (K Units)

Table 47. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)

Table 48. By Region, Asia-Pacific Antidepressants Market Size, 2019-2021 (US$ Million)

Table 49. By Region, Asia-Pacific Antidepressants Market Size, 2019-2021 (K Units)

Table 50. China Antidepressants Market Size, 2019-2021 (US$ Million) & (K Units)

Table 51. Japan Antidepressants Market Size, 2019-2021 (US$ Million) & (K Units)

Table 52. South Korea Antidepressants Market Size, 2019-2021 (US$ Million) & (K Units)

Table 53. India Antidepressants Market Size, 2019-2021 (US$ Million) & (K Units)

Table 54. ASEAN Antidepressants Market Size, 2019-2021 (US$ Million) & (K Units)

Table 55. Latin America Antidepressants Market Size, 2019-2021 (US$ Million) & (K Units)

Table 56. Middle East and Africa Antidepressants Market Size, 2019-2021 (US$ Million) & (K Units)

Table 57. H Lundbeck Business Overview

Table 58. H Lundbeck Antidepressants Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 59. H Lundbeck Antidepressants Product

Table 60. H Lundbeck Response to COVID-19 and Related Developments

Table 61. Astrazeneca Business Overview

Table 62. Astrazeneca Antidepressants Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 63. Astrazeneca Antidepressants Product

Table 64. Astrazeneca Response to COVID-19 and Related Developments

Table 65. Eli Lilly and Company Business Overview

Table 66. Eli Lilly and Company Antidepressants Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 67. Eli Lilly and Company Antidepressants Product

Table 68. Eli Lilly and Company Response to COVID-19 and Related Developments

Table 69. Sun Pharmaceuticals Business Overview

Table 70. Sun Pharmaceuticals Antidepressants Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 71. Sun Pharmaceuticals Antidepressants Product

Table 72. Sun Pharmaceuticals Response to COVID-19 and Related Developments

Table 73. Pfizer Inc. Business Overview

Table 74. Pfizer Inc. Antidepressants Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 75. Pfizer Inc. Antidepressants Product

Table 76. Pfizer Inc. Response to COVID-19 and Related Developments

Table 77. GlaxoSmithKline Business Overview

Table 78. GlaxoSmithKline Antidepressants Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 79. GlaxoSmithKline Antidepressants Product

Table 80. GlaxoSmithKline Response to COVID-19 and Related Developments

Table 81. Bristol-Myers Squibb Company Business Overview

Table 82. Bristol-Myers Squibb Company Antidepressants Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 83. Bristol-Myers Squibb Company Antidepressants Product

Table 84. Bristol-Myers Squibb Company Response to COVID-19 and Related Developments

Table 85. Johnson & Johnson Business Overview

Table 86. Johnson & Johnson Antidepressants Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 87. Johnson & Johnson Antidepressants Product

Table 88. Johnson & Johnson Response to COVID-19 and Related Developments

Table 89. Merck Business Overview

Table 90. Merck Antidepressants Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 91. Merck Antidepressants Product

Table 92. Merck Response to COVID-19 and Related Developments

Table 93. Sanofi Business Overview

Table 94. Sanofi Antidepressants Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 95. Sanofi Antidepressants Product

Table 96. Sanofi Response to COVID-19 and Related Developments

Table 97. Antidepressants Distributors List

Table 98. Antidepressants Customers List

Table 99. Covid-19 Impact on Antidepressants Customers

List of Figures

Figure 1. Antidepressants Product Picture

Figure 2. Antidepressants Market Segmentation

Figure 3. Research Objectives

Figure 4. Research Process

Figure 5. Data Triangulation

Figure 6. Research Approach

Figure 7. Commodity Prices-Metals Price Indices

Figure 8. Commodity Prices- Precious Metal Price Indices

Figure 9. Commodity Prices- Agricultural Raw Material Price Indices

Figure 10. Commodity Prices- Food and Beverage Price Indices

Figure 11. Commodity Prices- Fertilizer Price Indices

Figure 12. Commodity Prices- Energy Price Indices

Figure 13. G20+: Economic Policy Responses to COVID-19

Figure 14. Global Antidepressants Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)

Figure 15. Global Antidepressants Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)

Figure 16. Global Antidepressants Market Size, Quarterly Growth, 2020-2021 (%)

Figure 17. Global Antidepressants Market Size, Market Share by Type, 2019 VS 2020 (%)

Figure 18. Global Antidepressants Market Size, Market Share by Application, 2019 VS 2020 (%)

Figure 19. Global Antidepressants Market Size Market Share by Region, 2019 VS 2020 (%)

Figure 20. United States Composite PMI and GDP

Figure 21. Eurozone Composite PMI and GDP

Figure 22. Eurozone Core v. Periphery PMI Output Indices

Figure 23. Core v. Periphery PMI Employment Indices

Figure 24. UK Composite PMI and GDP

Figure 25. Caixin China Composite Output Index

Figure 26. Caixin China General Services Business Activity Index

Figure 27. Japan Composite Output Index

Figure 28. South Korea Manufacturing PMI

Figure 29. India Composite Output Index

Figure 30. ASEAN Manufacturing PMI

Figure 31. By Region, Asia-Pacific Antidepressants Market Size Market Share, 2019-2021

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3250

This license allows only one user(purchaser of the report) to access the PDF.

Multi User

Electronic (PDF)

$4875

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$6500

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (10% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

COVID-19 Impact on Antidepressants Market, Global Research Reports 2020-2021

Published Date: May 2020

Report Code: QYRE-Auto-10V2889

COVID-19 Impact on Antidepressants Market, Global Research Reports 2020-2021

FEATURED COMPANIES

FEATURED COMPANIES

FEATURED COMPANIES

HAVE A QUERY?

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-4O8609

Wed Apr 17 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-25I8231

Wed Apr 17 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-2M4266

Wed Apr 17 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-38E8328

Wed Apr 17 00:00:00 UTC 2024

Support Contacts

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

POLICIES

THE COMPANY

CUSTOMER SUPPORT

OUR PRODUCTS

POLICES

Copyright © 2018 Valuates.com. All Rights Reserved.

Sitemap - Privacy Policy - Terms & Conditions